Newly-released Terminal Sterilization Services Market analysis report by Future Market Insights shows that global sales of the Terminal Sterilization Services Market in 2021 were held at US$ 9.1 Billion. With a predicted growth between 2022 and 2032, at 12.7%, the market is likely to reach a valuation of US$ 33.5 Billion by 2032. Ethylene Oxide is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 14.4% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Terminal Sterilization Services Market Size (2022) | US$ 10.2 Billion |
| Global Terminal Sterilization Services Market Size (2032) | US$ 33.5 Billion |
| Global Terminal Sterilization Services Market CAGR (2022 to 2032) | 12.7% |
| USA Terminal Sterilization Services Market CAGR (2022 to 2032) | 11.8% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The market value of Terminal sterilization increased at a CAGR of around 10.9% from 2017 to 2021, according to a report done by Future Market Insights, a market research and competitive intelligence firm.
Due to the pandemic, the demand for terminal sterilization surged. Increasing R&D efforts in these industries lead to higher demand for various sterilization techniques, propelling market expansion throughout the projected period.
As per Pharmaceutical Researchers and Manufacturers Association, biopharmaceutical businesses in the USA spent about US$ 102 billion in research in 2018. USA Food and Drug Administration & European regulatory bodies have established rigorous standards and guidelines to maintain adequate control of aseptic work areas, such as suggesting and implementing Standard Operating Procedures to lessen the risk of toxicants being transmitted further into the drug processing areas.
Healthcare-Associated Infections (HAIs), the requirement to sterilize reusable high-risk or critical surgical instruments used in increasing surgical procedures, and the regulatory mandate of terminal sterilization or aseptic processing of healthcare products prior to commercialization, have led to the market growth.
The increasing trend of outsourcing sterilization services by the healthcare industry, and the continuous progressive refinement of various sterilization technologies, have further led to market growth. The gradual transition of the medical device market from reprocessed to value-enhanced single-use devices and the need to terminally sterilize a large volume of disposable devices, the steadily increasing and advancing healthcare facilities.
The terminal sterilization sector has gained pace in recent years as a result of surged awareness about diseases and infections caused by non-sterile settings. In addition, there has been a significant increase in funding for hospital infrastructure, research, and public health adaption to terminal sterility.
Companies can develop a sterilization program using the Association for the Advancement of Medical Instrumentation (AAMI) and ISO criteria without the requirement for a big and time-consuming Sterilization technology department. These voluntary consensus standards have also supplied regulatory agencies such as the FDA with a reference point for determining product sterility.
An increase in the occurrence of hospital-acquired infections (HAIs) due to a lack of sanitation and preventative measures is likely to drive the global market over the forecast period. Because it assists in the prevention of infections and disease transmission, sterilization equipment is required for sterilizing and cleaning a range of hospital equipment.
Furthermore, the Terminal Sterilization Services Market will be propelled ahead by the introduction of new products and technological advances in the sterilization process. The first novel medical equipment sterilization technique, the Ozone Sterilization system, has been authorized by the FDA. The maker of the ozone sterilization system is attempting to present this as a competitor with one of the most often used sterilizing technologies, ethylene oxide (EtO).
Despite its toxicity and lengthy aeration time, it is currently the most used 'cold' sterilizing method. TSO3 Inc., the maker, believes the technique is safer, quicker, and much more cost-effective than all those now used to sterilize medical equipment that cannot tolerate high heat or radiation.
In the future years, the Sterilization Services Market is predicted to develop at a high rate. The need for Sterilization Services is expected to surge as the number of hospital-acquired infections (HAIs) rises. Urinary and vascular catheter-associated infections, HIV infections, surgical site infections, hepatitis B and C, and ventilator-associated infections are the most prevalent HAIs caused by improper sterilizing practices. As technology becomes more accessible to both patients and clinicians, a variety of post-operative intervention options for reducing hospital re-admittance and complications are becoming available.
Active packaging technologies are being used more often in medical equipment, medicines, and products. Such devices absorb target pollutants within the packaging, extending the storability and quality of the products. Active packaging systems with O2 absorbers suggest an alternative for vacuum as well as gas-flushing methods.
Sterile Processing Method at Johnson & Johnson is always looking for ways to increase the storage life & consistency of sterilized medical equipment. Sterile Processing Method worked with CSP Technologies to see if its effective scavenging films might be a viable replacement to traditional gas flushing and purifying methods, as well as to verify CSP goods makes a claim that scavenging films continually eliminate O2 within a confined area to levels as low as 0.1 ppm.
Principal Consultant
North America is predicted to account for the largest share of the global terminal sterilization services market during the forecast period. A huge client base, greater usage of enhanced sterilization technologies, and highly modern healthcare infrastructure are projected to propel the market in North America in the next years.
Sterility Assurance Level (SAL), throughout North America, two healthcare SAL values have been utilized in procedure: 10-3 and 10-6, which represent the probability with one non-sterile unit in 1,000 or one million processing units, respectively. Because SAL is a potential contaminant, the lesser number, 10-6, gives more guarantee of sterility than that of the bigger number, 10-3.
The market in the Asia Pacific is predicted to have lucrative growth during the projection period, due to improved awareness of current technologies such as sterilization and disinfection among hospitals and clinics, labs and diagnostic centers, and pharmaceutical enterprises operating in the region. The Sterad Speed Biomedical Indicator/Process Challenging Instruments 15-minute duration to result was commercially available in Asia Pacific on August 25th, 2021, according to Advanced Sterilization Products.
The USA is expected to have the highest market of US$ 9.5 Billion by the end of 2032. Upsurge for terminal sterilization of medical products, packaging, and other items is being driven by a growth in the number of operations and the investment being done by the pharmaceutical companies.
In 2018, Eli Lilly announced a US$ 72 million investment in an insulin-manufacturing project in the USA. As an outcome, the demand for terminal sterilization is expected to rise in the forthcoming years. Also, MediZAP, North America's premier provider of e-beam terminal sterilization for compounded medications, partnered up with Analytic Laboratory, currently part of Element Materials Technology, to provide sterilized compounded testing facilities, analytical chemistry, & pharmaceutical customers.
The market in the United Kingdom is expected to gross an absolute dollar opportunity of US$ 1.4 Billion from 2022 to 2032. The market is expected to reach a valuation of US$ 1.9 Billion by 2032, growing at a CAGR of 14.5% during the forecast period.
In Japan, the market is projected to reach US$ 1.7 Billion by 2032. Growing at a CAGR of 18.2%, the market in the country is expected to garner an absolute dollar opportunity of US$ 1.4 Billion during the forecast period.
The market in South Korea grew at a CAGR of 10% from 2022 to 2032. The market is likely to grow further at a CAGR of 15.1% from 2022 to 2032 to reach a valuation of US$ 763 Million by 2032. During the forecast period, the market is expected to gross an absolute dollar opportunity of US$ 571 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market for the Ethylene Oxide segment is forecasted to grow at the highest CAGR of over 14% from 2022 to 2032. This increase is attributable to the increasing need for enhanced studies based on past patterns and datasets in order to create data-enriched insight that would assist enterprises in better understanding the present situation.
Andersen Products, Inc. offers Ethylene Oxide Sterilization Systems for sterilizing surgical equipment, optics, electrical equipment, and a variety of polymers. EOGas sterilizers from Andersen Products, Inc. combine innovative effective diffusion techniques with modern microprocessor control. The innovative unit-dose cartridge matches the actual load level, lowering gas usage significantly. Most products sterilize in an average cycle period of 16 hours, including aeration.
Some of the key players in the terminal sterilization services market include Johnson And Johnson, DuPont, Steris Plc, Getinge Group, Cantel Medical, Matachana Group, Sterigenics International LLC, and Olympus Corp.
The following are some of the most recent developments from key terminal sterilization service providers:
Similarly, recent developments related to companies in the terminal sterilization services market have been tracked by the team at Future Market Insights, which are available in the full report.
The Terminal Sterilization Services Market is worth more than US$ 9.1 Billion at present.
The value of the Terminal Sterilization Services Market is projected to increase at a CAGR of around 12.7% from 2022 to 2032.
The value of the Terminal Sterilization Services Market increased at a CAGR of around 10.9% from 2017 to 2021.
Advanced analytical solutions designed for specific requirements of healthcare companies and facilities delivering financial, clinical, operational, and administrative services are bolstering growth.
The market for Terminal Sterilization Services Market in China is projected to expand at a CAGR of around 14.6% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 15.1%, the market in Japan is projected to register a CAGR of nearly 18.2% from 2022 to 2032.
1. Executive Summary | Terminal Sterilization Services Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Investment Feasibility Matrix 3.4. Value Chain Analysis 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021 4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2017 to 2021 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2022 to 2032 5.3.1. Ethylene Oxide 5.3.2. Irradiation 5.3.3. Moist Heat Terminal Sterilization 5.3.4. Other Types 5.4. Y-o-Y Growth Trend Analysis By Type, 2017 to 2021 5.5. Absolute $ Opportunity Analysis By Type, 2022 to 2032 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032 6.3.1. Hospitals & Clinics 6.3.2. Pharma 6.3.3. Other End-uses 6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021 6.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. East Asia 7.3.5. South Asia 7.3.6. Oceania 7.3.7. Middle East and Africa(MEA) 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By End User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By End User 8.4. Key Takeaways 9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Argentina 9.2.1.4. Rest of Latin America 9.2.2. By Type 9.2.3. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End User 9.4. Key Takeaways 10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. Italy 10.2.1.3. France 10.2.1.4. United Kingdom 10.2.1.5. Spain 10.2.1.6. Russia 10.2.1.7. BENELUX 10.2.1.8. Rest of Europe 10.2.2. By Type 10.2.3. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End User 10.4. Key Takeaways 11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 11.2.1. By Country 11.2.1.1. China 11.2.1.2. Japan 11.2.1.3. South Korea 11.2.2. By Type 11.2.3. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End User 11.4. Key Takeaways 12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Thailand 12.2.1.3. Malaysia 12.2.1.4. Indonesia 12.2.1.5. Rest of South Asia 12.2.2. By Type 12.2.3. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End User 12.4. Key Takeaways 13. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Type 13.2.3. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. Rest of Middle East and Africa(MEA) 14.2.2. By Type 14.2.3. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Type 15.1.2.2. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Type 15.2.2.2. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Type 15.3.2.2. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Type 15.4.2.2. By End User 15.5. Argentina 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Type 15.5.2.2. By End User 15.6. Germany 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Type 15.6.2.2. By End User 15.7. Italy 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Type 15.7.2.2. By End User 15.8. France 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Type 15.8.2.2. By End User 15.9. United Kingdom 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Type 15.9.2.2. By End User 15.10. Spain 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Type 15.10.2.2. By End User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Type 15.11.2.2. By End User 15.12. BENELUX 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Type 15.12.2.2. By End User 15.13. China 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Type 15.13.2.2. By End User 15.14. Japan 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Type 15.14.2.2. By End User 15.15. South Korea 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Type 15.15.2.2. By End User 15.16. India 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2021 15.16.2.1. By Type 15.16.2.2. By End User 15.17. Thailand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2021 15.17.2.1. By Type 15.17.2.2. By End User 15.18. Malaysia 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2021 15.18.2.1. By Type 15.18.2.2. By End User 15.19. Indonesia 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2021 15.19.2.1. By Type 15.19.2.2. By End User 15.20. Australia 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2021 15.20.2.1. By Type 15.20.2.2. By End User 15.21. New Zealand 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2021 15.21.2.1. By Type 15.21.2.2. By End User 15.22. GCC Countries 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2021 15.22.2.1. By Type 15.22.2.2. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Johnson And Johnson 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. DuPont 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. Steris Plc 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Getinge Group 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Cantel Medical 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Matachana Group 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. Sterigenics International LLC 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Olympus Corp. 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments (Product/Age /Sales Channel/Region) 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Terminal Sterilization Services Market
